Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Betül Oran

1-50 of 77 results

View this query on the Wikidata Query Service
Cord-blood engraftment with ex vivo mesenchymal-cell coculture

scientific article published on December 2012
Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors.

scientific article
Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan

scientific article
Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation

scientific article published on 16 March 2015
IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation

scientific article published on 20 July 2016
Concise review: umbilical cord blood transplantation: past, present, and future

scientific article
Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation

scientific article published on 12 July 2016
Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation.

scientific article published on 31 May 2016
General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation

scientific article published on 20 February 2015
Allogeneic stem cell transplantation as initial salvage for patients with acute myeloid leukemia refractory to high-dose cytarabine-based induction chemotherapy

scientific article published on 7 March 2014
Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes.

scientific article
Allogeneic Transplantation in First Remission Improves Outcomes Irrespective of FLT3-ITD Allelic Ratio in FLT3-ITD-Positive Acute Myelogenous Leukemia

scientific article
Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment

scientific article
Cytogenetics, donor type, and use of hypomethylating agents in myelodysplastic syndrome with allogeneic stem cell transplantation.

scientific article
BFR (bendamustine, fludarabine, and rituximab) allogeneic conditioning for chronic lymphocytic leukemia/lymphoma: reduced myelosuppression and GVHD

scientific article
Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological Malignancies.

scientific article published on 7 February 2015
Can a female donor for a male recipient decrease the relapse rate for patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation?

scientific article
Better allele-level matching improves transplant-related mortality after double cord blood transplantation.

scientific article
Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation

scientific article
CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes

scientific article published on 20 June 2018
Age and Modified European LeukemiaNet Classification to Predict Transplant Outcomes: An Integrated Approach for Acute Myelogenous Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation

scientific article published on 31 March 2015
Relapse risk and survival in patients with FLT3 mutated acute myeloid leukemia undergoing stem cell transplantation

scientific article published on 4 January 2017
Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation

scientific article
Significance of persistent cytogenetic abnormalities on myeloablative allogeneic stem cell transplantation in first complete remission

scientific article
Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia

scientific article published on 18 August 2016
Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia

scientific article published on 04 September 2015
Minimal residual disease eradication with epigenetic therapy in core binding factor acute myeloid leukemia

scientific article published on 11 May 2017
Improvement in clinical outcome of FLT3 ITD mutated acute myeloid leukemia patients over the last one and a half decade

scientific article
Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid Leukemia

scientific article published on 12 February 2018
Comparison of survival in patients with T cell lymphoma after autologous and allogeneic stem cell transplantation as a frontline strategy or in relapsed disease

scientific article published on 31 January 2015
Haploidentical Transplantation for Older Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

scientific article published on 13 September 2017
The development of a myeloablative, reduced-toxicity, conditioning regimen for cord blood transplantation

scientific article published on 26 October 2013
Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies

scientific article
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission

scientific article published on 01 June 2019
Prolonged survival with a longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myeloma

scientific article published on 28 September 2016
Double umbilical cord blood transplant is effective therapy for relapsed or refractory Hodgkin lymphoma

scientific article published on 23 December 2015
Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-Term Study Results

scientific article published on 2 November 2016
Autologous Hematopoietic Stem Cell Transplantation in Dialysis-Dependent Myeloma Patients

scientific article published on 27 March 2015
Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantation

scientific article published on 18 October 2018
Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis

scientific article published on 24 January 2017
Allogeneic hematopoietic stem cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: a retrospective case-control study

scientific article
Conditioning with busulfan plus melphalan versus melphalan alone before autologous haemopoietic cell transplantation for multiple myeloma: an open-label, randomised, phase 3 trial

scientific article published on 22 March 2019
Predictive model for survival in patients with AML/MDS receiving haploidentical stem cell transplantation

scientific article published on 28 March 2017
Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes

scientific article published on September 1, 2013
Is a matched unrelated donor search needed for all allogeneic transplant candidates?

A randomized phase II trial of fludarabine/melphalan 100 versus fludarabine/melphalan 140 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma

scientific article
Impact of Fluid Overload as New Toxicity Category on Hematopoietic Stem Cell Transplantation Outcomes

scientific article published on 24 August 2017
Effect of non-permissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T cell depletion

scientific article published on 31 January 2018
Impact of a novel prognostic model, hematopoietic cell transplant-composite risk (HCT-CR), on allogeneic transplant outcomes in patients with acute myeloid leukemia and myelodysplastic syndrome

scientific article published on 26 September 2018
Cytarabine, Ki‐67, and SOX11 in patients with mantle cell lymphoma receiving rituximab‐containing autologous stem cell transplantation during first remission

scientific article published on June 17, 2013

Paulina is supported by:

About Paulina

Help